Drug Profile
Dolutegravir/lamivudine/tenofovir disoproxil fumarate - CELLTRION
Alternative Names: Dolutegravir/lamivudine/tenofovir - CELLTRION; Tenofovir disoproxil fumarate/dolutegravir/lamivudine - CELLTRION; Tenofovir disoproxil fumarate/lamivudine/dolutegravir - CELLTRIONLatest Information Update: 13 May 2020
Price :
$50
*
At a glance
- Originator Celltrion
- Class 3-ring heterocyclic compounds; Amides; Antiretrovirals; Deoxyribonucleosides; Dideoxynucleosides; Oxazines; Phosphonic acids; Purines; Pyrimidine nucleosides; Small molecules
- Mechanism of Action HIV integrase inhibitors; Nucleoside reverse transcriptase inhibitors; Nucleotide reverse transcriptase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Registered HIV-1 infections